Epigenetic regulation of p63 blocks squamous-to-neuroendocrine transdifferentiation in esophageal development and malignancy.
Cell Transdifferentiation
/ genetics
Humans
Esophageal Neoplasms
/ genetics
Animals
Esophagus
/ metabolism
Epigenesis, Genetic
Mice
Tumor Suppressor Proteins
/ metabolism
Gene Expression Regulation, Neoplastic
Trans-Activators
/ metabolism
Cell Line, Tumor
Carcinoma, Neuroendocrine
/ metabolism
Enhancer of Zeste Homolog 2 Protein
/ metabolism
Transcription Factors
/ metabolism
Neuroendocrine Cells
/ metabolism
Journal
Science advances
ISSN: 2375-2548
Titre abrégé: Sci Adv
Pays: United States
ID NLM: 101653440
Informations de publication
Date de publication:
11 Oct 2024
11 Oct 2024
Historique:
medline:
9
10
2024
pubmed:
9
10
2024
entrez:
9
10
2024
Statut:
ppublish
Résumé
While cell fate determination and maintenance are important in establishing and preserving tissue identity and function during development, aberrant cell fate transition leads to cancer cell heterogeneity and resistance to treatment. Here, we report an unexpected role for the transcription factor p63 (Trp63/TP63) in the fate choice of the squamous versus neuroendocrine lineage in esophageal development and malignancy. Deletion of
Identifiants
pubmed: 39383220
doi: 10.1126/sciadv.adq0479
doi:
Substances chimiques
TP63 protein, human
0
Tumor Suppressor Proteins
0
Trp63 protein, mouse
0
Trans-Activators
0
Enhancer of Zeste Homolog 2 Protein
EC 2.1.1.43
Transcription Factors
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM